Skip to main content
Erschienen in: Journal of Neural Transmission 3/2017

23.11.2016 | Neurology and Preclinical Neurological Studies - Original Article

Motion and emotion: anxiety–axial connections in Parkinson’s disease

verfasst von: Rastislav Šumec, Irena Rektorová, Robert Jech, Kateřina Menšíková, Jan Roth, Evžen Růžička, Dana Sochorová, Ladislav Dušek, Petr Kaňovský, Ivan Rektor, Tomáš Pavlík, Pavel Filip, Martin Bareš

Erschienen in: Journal of Neural Transmission | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Anxiety is a serious and frequent complication in Parkinson’s disease (PD) that significantly affects the quality of life of patients. Multiple neuroanatomical, experimental, and clinical studies suggest its close association with axial disturbances. However, whether this relation applies for PD patients (commonly suffering from axial difficulties, such as balance and gait disturbance) has not been properly tested yet. The purpose of this study was to determine whether PD patients suffering from axial symptoms have higher levels of anxiety than others and to identify other factors associated with anxiety–axial connections. In this questionnaire study, 212 patients with PD were assessed by standardized scales, such as Hamilton Anxiety Scale, Montgomery–Asberg Depression Rating Scale, Montreal Cognitive Assessment, examining their mood and cognitive status. These data were correlated to dominant motor symptoms of these patients, such as tremor, rigidity, bradykinesia, and axial symptoms. Unlike other motor symptoms, only axial symptoms showed to be significantly related to higher levels of anxiety. The patients suffering from anxiety and axial problems have also shown significantly higher depression levels. Axial disturbances are related to higher anxiety levels in PD patients. It is crucial to pay high attention to symptoms of anxiety in patients having postural instability or gait disorder. Further clinical studies are desirable to investigate new, practical implications of anxiety–axial connection to provide complex management options of these serious symptoms.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Adkin AL, Frank JS, Jog MS (2003) Fear of falling and postural control in Parkinson’s disease. Mov Disord 18:496–502CrossRefPubMed Adkin AL, Frank JS, Jog MS (2003) Fear of falling and postural control in Parkinson’s disease. Mov Disord 18:496–502CrossRefPubMed
Zurück zum Zitat American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, Fifth edn. American Psychiatric Publishing, Arlington, VA, p 189CrossRef American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, Fifth edn. American Psychiatric Publishing, Arlington, VA, p 189CrossRef
Zurück zum Zitat Anguenot A, Loll PY, Neau JP, Ingrand P, Gil R (2002) Depression and Parkinson’s Disease: study of a series of 135 Parkinson’s patients. Can J Neurol Sci 29:139–146PubMed Anguenot A, Loll PY, Neau JP, Ingrand P, Gil R (2002) Depression and Parkinson’s Disease: study of a series of 135 Parkinson’s patients. Can J Neurol Sci 29:139–146PubMed
Zurück zum Zitat Balaban CD (1996) Vestibular nucleus projections to the parabrachial nucleus in rabbits: implications for vestibular influences on the autonomic nervous system. Exp Brain Res 108:367–381CrossRefPubMed Balaban CD (1996) Vestibular nucleus projections to the parabrachial nucleus in rabbits: implications for vestibular influences on the autonomic nervous system. Exp Brain Res 108:367–381CrossRefPubMed
Zurück zum Zitat Balaban CD, Thayer JF (2001) Neurological bases for balance-anxiety links. J Anxiety Disord 15:53–79CrossRefPubMed Balaban CD, Thayer JF (2001) Neurological bases for balance-anxiety links. J Anxiety Disord 15:53–79CrossRefPubMed
Zurück zum Zitat Bares M, Rektorova I, Jech R, Farnikova K, Roth J, Ruzicka E, Kanovsky P, Rektor I, Pavlik T, Uhlirova L, Vydlak J (2012) Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson’s disease? J Neural Trans (Vienna) 119:373–380CrossRef Bares M, Rektorova I, Jech R, Farnikova K, Roth J, Ruzicka E, Kanovsky P, Rektor I, Pavlik T, Uhlirova L, Vydlak J (2012) Does WOQ-9 help to recognize symptoms of non-motor wearing-off in Parkinson’s disease? J Neural Trans (Vienna) 119:373–380CrossRef
Zurück zum Zitat Bart O, Bar-Haim Y, Weizman E, Levin M, Sadeh A, Mintz M (2009) Balance treatment ameliorates anxiety and increases self-esteem in children with comorbid anxiety and balance disorder. Res Dev Disabil 30:486–495CrossRefPubMed Bart O, Bar-Haim Y, Weizman E, Levin M, Sadeh A, Mintz M (2009) Balance treatment ameliorates anxiety and increases self-esteem in children with comorbid anxiety and balance disorder. Res Dev Disabil 30:486–495CrossRefPubMed
Zurück zum Zitat Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH (2001) Prospective assessment of falls in Parkinson’s disease. J Neurol 248:950–958CrossRefPubMed Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH (2001) Prospective assessment of falls in Parkinson’s disease. J Neurol 248:950–958CrossRefPubMed
Zurück zum Zitat Bostantjopoulou S, Katsarou Z, Karakasis C, Peitsidou E, Milioni D, Rossopoulos N (2013) Evaluation of non-motor symptoms in Parkinson’s disease: an underestimated necessity. Hippokratia 17:214–219PubMedPubMedCentral Bostantjopoulou S, Katsarou Z, Karakasis C, Peitsidou E, Milioni D, Rossopoulos N (2013) Evaluation of non-motor symptoms in Parkinson’s disease: an underestimated necessity. Hippokratia 17:214–219PubMedPubMedCentral
Zurück zum Zitat Brown RG, Landau S, Hindle JV, Playfer J, Samuel M, Wilson KC, Hurt CS, Anderson RJ, Carnell J, Dickinson L, Gibson G, van Schaick R, Sellwood K, Thomas BA, Burn DJ, PROMS-PD Study Group (2011) Depression and anxiety related subtypes in Parkinson’s disease. J Neurol Neurosurg Psychiatry 82:803–809CrossRefPubMed Brown RG, Landau S, Hindle JV, Playfer J, Samuel M, Wilson KC, Hurt CS, Anderson RJ, Carnell J, Dickinson L, Gibson G, van Schaick R, Sellwood K, Thomas BA, Burn DJ, PROMS-PD Study Group (2011) Depression and anxiety related subtypes in Parkinson’s disease. J Neurol Neurosurg Psychiatry 82:803–809CrossRefPubMed
Zurück zum Zitat Bryant MS, Rintala DH, Hou JG, Protas EJ (2014) Influence of fear of falling on gait and balance in Parkinson’s disease. Disabil Rehabil 36:744–748CrossRefPubMed Bryant MS, Rintala DH, Hou JG, Protas EJ (2014) Influence of fear of falling on gait and balance in Parkinson’s disease. Disabil Rehabil 36:744–748CrossRefPubMed
Zurück zum Zitat Burn DJ, Landau S, Hindle JV, Samuel M, Wilson KC, Hurt CS, Brown RG, PROMS-PD Study Group (2012) Parkinson’s disease motor subtypes and mood. Mov Disord 27:379–386CrossRefPubMed Burn DJ, Landau S, Hindle JV, Samuel M, Wilson KC, Hurt CS, Brown RG, PROMS-PD Study Group (2012) Parkinson’s disease motor subtypes and mood. Mov Disord 27:379–386CrossRefPubMed
Zurück zum Zitat Casacchia M, Zamponi A, Squitieri G, Meco G (1975) Treatment of anxiety in Parkinson’s disease with bromazepam. Riv Neurol 45:326–338PubMed Casacchia M, Zamponi A, Squitieri G, Meco G (1975) Treatment of anxiety in Parkinson’s disease with bromazepam. Riv Neurol 45:326–338PubMed
Zurück zum Zitat Charney DS, Deutch A (1996) A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 10:419–446CrossRefPubMed Charney DS, Deutch A (1996) A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 10:419–446CrossRefPubMed
Zurück zum Zitat Davison GC (2008) Abnormal Psychology. Veronica Visentin, Toronto, p 154 Davison GC (2008) Abnormal Psychology. Veronica Visentin, Toronto, p 154
Zurück zum Zitat Dissanayaka NN, Sellbach A, Matheson S, O’Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD (2010) Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov Disord 25:838–845CrossRefPubMed Dissanayaka NN, Sellbach A, Matheson S, O’Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD (2010) Anxiety disorders in Parkinson’s disease: prevalence and risk factors. Mov Disord 25:838–845CrossRefPubMed
Zurück zum Zitat Dissanayaka NN, White E, O’Sullivan JD, Marsh R, Pachana NA, Byrne GJ (2014) The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord 29:967–975CrossRefPubMed Dissanayaka NN, White E, O’Sullivan JD, Marsh R, Pachana NA, Byrne GJ (2014) The clinical spectrum of anxiety in Parkinson’s disease. Mov Disord 29:967–975CrossRefPubMed
Zurück zum Zitat Ehgoetz Martens KA, Ellard CG, Almeida QJ (2015a) Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson’s disease. Eur J Neurosci 42:2028–2035CrossRefPubMed Ehgoetz Martens KA, Ellard CG, Almeida QJ (2015a) Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson’s disease. Eur J Neurosci 42:2028–2035CrossRefPubMed
Zurück zum Zitat Ehgoetz Martens KA, Ellard CG, Almeida QJ (2015b) Virtually induced threat in Parkinson’s: dopaminergic interactions between anxiety and sensory-perceptual processing while walking. Neuropsychologia 79:322–331CrossRefPubMed Ehgoetz Martens KA, Ellard CG, Almeida QJ (2015b) Virtually induced threat in Parkinson’s: dopaminergic interactions between anxiety and sensory-perceptual processing while walking. Neuropsychologia 79:322–331CrossRefPubMed
Zurück zum Zitat Elbers RG, van Wegen EE, Verhoef J, Kwakkel G (2013) Is gait speed a valid measure to predict community ambulation in patients with Parkinson’s disease? J Rehabil Med 45:370–375CrossRefPubMed Elbers RG, van Wegen EE, Verhoef J, Kwakkel G (2013) Is gait speed a valid measure to predict community ambulation in patients with Parkinson’s disease? J Rehabil Med 45:370–375CrossRefPubMed
Zurück zum Zitat Ellis T, Boudreau JK, DeAngelis TR, Brown LE, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE (2013) Barriers to exercise in people with Parkinson disease. Phys Ther 93:628–636CrossRefPubMedPubMedCentral Ellis T, Boudreau JK, DeAngelis TR, Brown LE, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE (2013) Barriers to exercise in people with Parkinson disease. Phys Ther 93:628–636CrossRefPubMedPubMedCentral
Zurück zum Zitat Eysenck MW, MacLeod C, Mathews A (1987) Cognitive functioning and anxiety. Psychol Res 49:189–195CrossRefPubMed Eysenck MW, MacLeod C, Mathews A (1987) Cognitive functioning and anxiety. Psychol Res 49:189–195CrossRefPubMed
Zurück zum Zitat Franchignoni F, Martignoni E, Ferriero G, Pasetti C (2005) Balance and fear of falling in Parkinson’s disease. Parkinsonism Relat Disord 11:427–433CrossRefPubMed Franchignoni F, Martignoni E, Ferriero G, Pasetti C (2005) Balance and fear of falling in Parkinson’s disease. Parkinsonism Relat Disord 11:427–433CrossRefPubMed
Zurück zum Zitat Gallagher DA, Schrag A (2012) Psychosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Dis 46:581–589CrossRefPubMed Gallagher DA, Schrag A (2012) Psychosis, apathy, depression and anxiety in Parkinson’s disease. Neurobiol Dis 46:581–589CrossRefPubMed
Zurück zum Zitat Goddard AW, Charney DS (1997) Toward an integrated neurobiology of panic disorder. J Clin Psychiatry 58(Suppl 2):4–11 (discussion 11–2) PubMed Goddard AW, Charney DS (1997) Toward an integrated neurobiology of panic disorder. J Clin Psychiatry 58(Suppl 2):4–11 (discussion 11–2) PubMed
Zurück zum Zitat Goetz CG (2010) New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson’s disease. Mov Disord 25(Suppl 1):S104–S109CrossRefPubMed Goetz CG (2010) New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson’s disease. Mov Disord 25(Suppl 1):S104–S109CrossRefPubMed
Zurück zum Zitat Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2004) Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease (2004) Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19:1020–1028CrossRefPubMed
Zurück zum Zitat Hely MA, Morris JG, Traficante R, Reid WG, O’Sullivan DJ, Williamson PM (1999) The sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 67:300–307CrossRefPubMedPubMedCentral Hely MA, Morris JG, Traficante R, Reid WG, O’Sullivan DJ, Williamson PM (1999) The sydney multicentre study of Parkinson’s disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 67:300–307CrossRefPubMedPubMedCentral
Zurück zum Zitat Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376CrossRefPubMed Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376CrossRefPubMed
Zurück zum Zitat Jiang SM, Yuan YS, Tong Q, Zhang L, Xu QR, Ding J, Zhang KZ (2015) The association between clinically relevant anxiety and other non-motor symptoms in Parkinson’s disease. Neurol Sci 36:2105–2109CrossRefPubMed Jiang SM, Yuan YS, Tong Q, Zhang L, Xu QR, Ding J, Zhang KZ (2015) The association between clinically relevant anxiety and other non-motor symptoms in Parkinson’s disease. Neurol Sci 36:2105–2109CrossRefPubMed
Zurück zum Zitat Kandiah N, Zhang A, Cenina AR, Au WL, Nadkarni N, Tan LC (2014) Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson’s disease. Parkinsonism Relat Disord 20:1145–1148CrossRefPubMed Kandiah N, Zhang A, Cenina AR, Au WL, Nadkarni N, Tan LC (2014) Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson’s disease. Parkinsonism Relat Disord 20:1145–1148CrossRefPubMed
Zurück zum Zitat Ketharanathan T, Hanwella R, Weerasundera R, de Silva VA (2016) Diagnostic validity and factor analysis of Montgomery-Asberg Depression Rating Scale in Parkinson disease population. J Geriatr Psychiatry Neurol 29:115–119CrossRefPubMed Ketharanathan T, Hanwella R, Weerasundera R, de Silva VA (2016) Diagnostic validity and factor analysis of Montgomery-Asberg Depression Rating Scale in Parkinson disease population. J Geriatr Psychiatry Neurol 29:115–119CrossRefPubMed
Zurück zum Zitat Kummer A, Cardoso F, Teixeira AL (2008) Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson’s disease. Mov Disord 23:1739–1743CrossRefPubMed Kummer A, Cardoso F, Teixeira AL (2008) Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson’s disease. Mov Disord 23:1739–1743CrossRefPubMed
Zurück zum Zitat Kummer A, Cardoso F, Teixeira AL (2009) Suicidal ideation in Parkinson’s disease. CNS Spectr 14:431–436CrossRefPubMed Kummer A, Cardoso F, Teixeira AL (2009) Suicidal ideation in Parkinson’s disease. CNS Spectr 14:431–436CrossRefPubMed
Zurück zum Zitat Kurlan R (2005) “Fear of falling” gait: a potentially reversible psychogenic gait disorder. Cogn Behav Neurol 18:171–172CrossRefPubMed Kurlan R (2005) “Fear of falling” gait: a potentially reversible psychogenic gait disorder. Cogn Behav Neurol 18:171–172CrossRefPubMed
Zurück zum Zitat Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008) Anxiety rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 23:2015–2025CrossRefPubMed Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008) Anxiety rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 23:2015–2025CrossRefPubMed
Zurück zum Zitat Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE (2011a) Symptomatology and markers of anxiety disorders in Parkinson’s disease: a cross-sectional study. Mov Disord 26:484–492CrossRefPubMed Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE (2011a) Symptomatology and markers of anxiety disorders in Parkinson’s disease: a cross-sectional study. Mov Disord 26:484–492CrossRefPubMed
Zurück zum Zitat Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P (2011b) Anxiety rating scales in Parkinson’s disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord 26:407–415CrossRefPubMed Leentjens AF, Dujardin K, Marsh L, Richard IH, Starkstein SE, Martinez-Martin P (2011b) Anxiety rating scales in Parkinson’s disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord 26:407–415CrossRefPubMed
Zurück zum Zitat Lindholm B, Hagell P, Hansson O, Nilsson MH (2014) Factors associated with fear of falling in people with Parkinson’s disease. BMC Neurol 14:19CrossRefPubMedPubMedCentral Lindholm B, Hagell P, Hansson O, Nilsson MH (2014) Factors associated with fear of falling in people with Parkinson’s disease. BMC Neurol 14:19CrossRefPubMedPubMedCentral
Zurück zum Zitat Lohnes CA, Earhart GM (2010) External validation of abbreviated versions of the activities-specific balance confidence scale in Parkinson’s disease. Mov Disord 25:485–489CrossRefPubMedPubMedCentral Lohnes CA, Earhart GM (2010) External validation of abbreviated versions of the activities-specific balance confidence scale in Parkinson’s disease. Mov Disord 25:485–489CrossRefPubMedPubMedCentral
Zurück zum Zitat Mak MK, Pang MY, Mok V (2012) Gait difficulty, postural instability, and muscle weakness are associated with fear of falling in people with Parkinson’s disease. Parkinsons Dis 2012:901721PubMed Mak MK, Pang MY, Mok V (2012) Gait difficulty, postural instability, and muscle weakness are associated with fear of falling in people with Parkinson’s disease. Parkinsons Dis 2012:901721PubMed
Zurück zum Zitat Marinus J, Leentjens AF, Visser M, Stiggelbout AM, van Hilten JJ (2002) Evaluation of the hospital anxiety and depression scale in patients with Parkinson’s disease. Clin Neuropharmacol 25:318–324CrossRefPubMed Marinus J, Leentjens AF, Visser M, Stiggelbout AM, van Hilten JJ (2002) Evaluation of the hospital anxiety and depression scale in patients with Parkinson’s disease. Clin Neuropharmacol 25:318–324CrossRefPubMed
Zurück zum Zitat Martinez-Martin P, Rojo-Abuin JM, Dujardin K, Pontone GM, Weintraub D, Forjaz MJ, Starkstein S, Leentjens AF (2013) Designing a new scale to measure anxiety symptoms in Parkinson’s disease: item selection based on canonical correlation analysis. Eur J Neurol 20:1198–1203CrossRefPubMed Martinez-Martin P, Rojo-Abuin JM, Dujardin K, Pontone GM, Weintraub D, Forjaz MJ, Starkstein S, Leentjens AF (2013) Designing a new scale to measure anxiety symptoms in Parkinson’s disease: item selection based on canonical correlation analysis. Eur J Neurol 20:1198–1203CrossRefPubMed
Zurück zum Zitat Matheson SF, Byrne GJ, Dissanayaka NN, Pachana NA, Mellick GD, O’Sullivan JD, Silburn PA, Sellbach A, Marsh R (2012) Validity and reliability of the Geriatric Anxiety Inventory in Parkinson’s disease. Australas J Ageing 31:13–16CrossRefPubMed Matheson SF, Byrne GJ, Dissanayaka NN, Pachana NA, Mellick GD, O’Sullivan JD, Silburn PA, Sellbach A, Marsh R (2012) Validity and reliability of the Geriatric Anxiety Inventory in Parkinson’s disease. Australas J Ageing 31:13–16CrossRefPubMed
Zurück zum Zitat McDowell I (2006) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, OxfordCrossRef McDowell I (2006) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, OxfordCrossRef
Zurück zum Zitat Melton LJ, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, Rocca WA (2006) Fracture risk after the diagnosis of Parkinson’s disease: influence of concomitant dementia. Mov Disord 21:1361–1367CrossRefPubMed Melton LJ, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, Rocca WA (2006) Fracture risk after the diagnosis of Parkinson’s disease: influence of concomitant dementia. Mov Disord 21:1361–1367CrossRefPubMed
Zurück zum Zitat Menza M, Marin H, Kaufman K, Mark M, Lauritano M (2004) Citalopram treatment of depression in Parkinson’s disease: the impact on anxiety, disability, and cognition. J Neuropsychiatry Clin Neurosci 16:315–319CrossRefPubMed Menza M, Marin H, Kaufman K, Mark M, Lauritano M (2004) Citalopram treatment of depression in Parkinson’s disease: the impact on anxiety, disability, and cognition. J Neuropsychiatry Clin Neurosci 16:315–319CrossRefPubMed
Zurück zum Zitat Mondolo F, Jahanshahi M, Grana A, Biasutti E, Cacciatori E, Di Benedetto P (2007) Evaluation of anxiety in Parkinson’s disease with some commonly used rating scales. Neurol Sci 28:270–275CrossRefPubMed Mondolo F, Jahanshahi M, Grana A, Biasutti E, Cacciatori E, Di Benedetto P (2007) Evaluation of anxiety in Parkinson’s disease with some commonly used rating scales. Neurol Sci 28:270–275CrossRefPubMed
Zurück zum Zitat Muller-Thomsen T, Arlt S, Mann U, Mass R, Ganzer S (2005) Detecting depression in Alzheimer’s disease: evaluation of four different scales. Arch Clin Neuropsychol 20:271–276CrossRefPubMed Muller-Thomsen T, Arlt S, Mann U, Mass R, Ganzer S (2005) Detecting depression in Alzheimer’s disease: evaluation of four different scales. Arch Clin Neuropsychol 20:271–276CrossRefPubMed
Zurück zum Zitat Negre-Pages L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lepine JP, Rascol O, DoPaMiP Study Group (2010) Anxious and depressive symptoms in Parkinson’s disease: the French cross-sectionnal DoPaMiP study. Mov Disord 25:157–166CrossRefPubMed Negre-Pages L, Grandjean H, Lapeyre-Mestre M, Montastruc JL, Fourrier A, Lepine JP, Rascol O, DoPaMiP Study Group (2010) Anxious and depressive symptoms in Parkinson’s disease: the French cross-sectionnal DoPaMiP study. Mov Disord 25:157–166CrossRefPubMed
Zurück zum Zitat Nilsson MH, Hariz GM, Iwarsson S, Hagell P (2012) Walking ability is a major contributor to fear of falling in people with Parkinson’s disease: implications for rehabilitation. Parkinsons Dis 2012:713236PubMed Nilsson MH, Hariz GM, Iwarsson S, Hagell P (2012) Walking ability is a major contributor to fear of falling in people with Parkinson’s disease: implications for rehabilitation. Parkinsons Dis 2012:713236PubMed
Zurück zum Zitat Pasman EP, Murnaghan CD, Bloem BR, Carpenter MG (2011) Balance problems with Parkinson’s disease: are they anxiety-dependent? Neuroscience 177:283–291CrossRefPubMed Pasman EP, Murnaghan CD, Bloem BR, Carpenter MG (2011) Balance problems with Parkinson’s disease: are they anxiety-dependent? Neuroscience 177:283–291CrossRefPubMed
Zurück zum Zitat Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord 24:1333–1338CrossRefPubMedPubMedCentral Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SA, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L (2009) Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord 24:1333–1338CrossRefPubMedPubMedCentral
Zurück zum Zitat Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, Mas N, Hofeneder D, Brucke T, Bayes A, Wenzel K, Infante J, Zach H, Pirker W, Posada IJ, Alvarez R, Ispierto L, De Fabregues O, Callen A, Palasi A, Aguilar M, Marti MJ, Valldeoriola F, Salamero M, Poewe W, Tolosa E (2015) The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord 30:229–237CrossRefPubMed Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, Mas N, Hofeneder D, Brucke T, Bayes A, Wenzel K, Infante J, Zach H, Pirker W, Posada IJ, Alvarez R, Ispierto L, De Fabregues O, Callen A, Palasi A, Aguilar M, Marti MJ, Valldeoriola F, Salamero M, Poewe W, Tolosa E (2015) The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord 30:229–237CrossRefPubMed
Zurück zum Zitat Prediger RD, Matheus FC, Schwarzbold ML, Lima MM, Vital MA (2012) Anxiety in Parkinson’s disease: a critical review of experimental and clinical studies. Neuropharmacology 62:115–124CrossRefPubMed Prediger RD, Matheus FC, Schwarzbold ML, Lima MM, Vital MA (2012) Anxiety in Parkinson’s disease: a critical review of experimental and clinical studies. Neuropharmacology 62:115–124CrossRefPubMed
Zurück zum Zitat Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1434CrossRefPubMed Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson’s disease: the relative importance of the symptoms. Mov Disord 23:1428–1434CrossRefPubMed
Zurück zum Zitat Reppa GP (2013) The effects of a new program (balance & reform) on trait anxiety and self- esteem: a pilot study. Proc Soc Behav Sci 84:230–232CrossRef Reppa GP (2013) The effects of a new program (balance & reform) on trait anxiety and self- esteem: a pilot study. Proc Soc Behav Sci 84:230–232CrossRef
Zurück zum Zitat Rinalduzzi S, Trompetto C, Marinelli L, Alibardi A, Missori P, Fattapposta F, Pierelli F, Curra A (2015) Balance dysfunction in Parkinson’s disease. Biomed Res Int 2015:434683CrossRefPubMedPubMedCentral Rinalduzzi S, Trompetto C, Marinelli L, Alibardi A, Missori P, Fattapposta F, Pierelli F, Curra A (2015) Balance dysfunction in Parkinson’s disease. Biomed Res Int 2015:434683CrossRefPubMedPubMedCentral
Zurück zum Zitat Rosenhan DL, Seligman M, Walke EF (2001) Abnormal psychology. W W Norton & Co Inc, New York Rosenhan DL, Seligman M, Walke EF (2001) Abnormal psychology. W W Norton & Co Inc, New York
Zurück zum Zitat Routh LC, Black JL, Ahlskog JE (1987) Parkinson’s disease complicated by anxiety. Mayo Clin Proc 62:733–735CrossRefPubMed Routh LC, Black JL, Ahlskog JE (1987) Parkinson’s disease complicated by anxiety. Mayo Clin Proc 62:733–735CrossRefPubMed
Zurück zum Zitat Sagna A, Gallo JJ, Pontone GM (2014) Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease. Parkinsonism Relat Disord 20:708–715CrossRefPubMedPubMedCentral Sagna A, Gallo JJ, Pontone GM (2014) Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson’s disease. Parkinsonism Relat Disord 20:708–715CrossRefPubMedPubMedCentral
Zurück zum Zitat Scalzo PL, Flores CR, Marques JR, Robini SC, Teixeira AL (2012) Impact of changes in balance and walking capacity on the quality of life in patients with Parkinson’s disease. Arq Neuropsiquiatr 70:119–124CrossRefPubMed Scalzo PL, Flores CR, Marques JR, Robini SC, Teixeira AL (2012) Impact of changes in balance and walking capacity on the quality of life in patients with Parkinson’s disease. Arq Neuropsiquiatr 70:119–124CrossRefPubMed
Zurück zum Zitat Shefer S, Gordon C, Avraham KB, Mintz M (2015) Balance deficit enhances anxiety and balance training decreases anxiety in vestibular mutant mice. Behav Brain Res 276:76–83CrossRefPubMed Shefer S, Gordon C, Avraham KB, Mintz M (2015) Balance deficit enhances anxiety and balance training decreases anxiety in vestibular mutant mice. Behav Brain Res 276:76–83CrossRefPubMed
Zurück zum Zitat Shulman L, Singer C, Liefert R, Mellman T, Weiner W (1996) Therapeutic effects of sertraline in patients with Parkinson’s disease. Movement disorders 11:12 Shulman L, Singer C, Liefert R, Mellman T, Weiner W (1996) Therapeutic effects of sertraline in patients with Parkinson’s disease. Movement disorders 11:12
Zurück zum Zitat Siemers ER, Shekhar A, Quaid K, Dickson H (1993) Anxiety and motor performance in Parkinson’s disease. Mov Disord 8:501–506CrossRefPubMed Siemers ER, Shekhar A, Quaid K, Dickson H (1993) Anxiety and motor performance in Parkinson’s disease. Mov Disord 8:501–506CrossRefPubMed
Zurück zum Zitat Sumec R, Filip P, Sheardova K, Bares M (2015) Psychological benefits of nonpharmacological methods aimed for improving balance in Parkinson’s disease: a systematic review. Behav Neurol 2015:620674CrossRefPubMedPubMedCentral Sumec R, Filip P, Sheardova K, Bares M (2015) Psychological benefits of nonpharmacological methods aimed for improving balance in Parkinson’s disease: a systematic review. Behav Neurol 2015:620674CrossRefPubMedPubMedCentral
Zurück zum Zitat Tarczy M, Szombathelyi E (1998) Depression in Parkinson’s disease with special regard to anxiety: experiences with paroxetine treatment. Mov Disord 13:275CrossRef Tarczy M, Szombathelyi E (1998) Depression in Parkinson’s disease with special regard to anxiety: experiences with paroxetine treatment. Mov Disord 13:275CrossRef
Zurück zum Zitat Thomas AA, Rogers JM, Amick MM, Friedman JH (2010) Falls and the falls efficacy scale in Parkinson’s disease. J Neurol 257:1124–1128CrossRefPubMed Thomas AA, Rogers JM, Amick MM, Friedman JH (2010) Falls and the falls efficacy scale in Parkinson’s disease. J Neurol 257:1124–1128CrossRefPubMed
Zurück zum Zitat Troeung L, Egan SJ, Gasson N (2013) A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson’s disease. PLoS One 8:e79510CrossRefPubMedPubMedCentral Troeung L, Egan SJ, Gasson N (2013) A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson’s disease. PLoS One 8:e79510CrossRefPubMedPubMedCentral
Zurück zum Zitat Vaccarino AL, Evans KR, Sills TL, Kalali AH (2008) Symptoms of anxiety in depression: assessment of item performance of the hamilton anxiety rating scale in patients with depression. Depress Anxiety 25:1006–1013CrossRefPubMed Vaccarino AL, Evans KR, Sills TL, Kalali AH (2008) Symptoms of anxiety in depression: assessment of item performance of the hamilton anxiety rating scale in patients with depression. Depress Anxiety 25:1006–1013CrossRefPubMed
Zurück zum Zitat Williams JB, Kobak KA (2008) Development and reliability of a structured interview guide for the montgomery asberg depression rating scale (SIGMA). Br J Psychiatry 192:52–58CrossRefPubMed Williams JB, Kobak KA (2008) Development and reliability of a structured interview guide for the montgomery asberg depression rating scale (SIGMA). Br J Psychiatry 192:52–58CrossRefPubMed
Metadaten
Titel
Motion and emotion: anxiety–axial connections in Parkinson’s disease
verfasst von
Rastislav Šumec
Irena Rektorová
Robert Jech
Kateřina Menšíková
Jan Roth
Evžen Růžička
Dana Sochorová
Ladislav Dušek
Petr Kaňovský
Ivan Rektor
Tomáš Pavlík
Pavel Filip
Martin Bareš
Publikationsdatum
23.11.2016
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 3/2017
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-016-1652-0

Weitere Artikel der Ausgabe 3/2017

Journal of Neural Transmission 3/2017 Zur Ausgabe

Neurology and Preclinical Neurological Studies - Original Article

Attention in Parkinson’s disease with fatigue: evidence from the attention network test

Neurology and Preclinical Neurological Studies - Original Article

Discussing sexuality with patients with Parkinson’s disease: a survey among Dutch neurologists

Psychiatry and Preclinical Psychiatric Studies - Original Article

The differential relationship between trait anxiety, depression, and resting frontal α-asymmetry

Neurology and Preclinical Neurological Studies - Original Article

A prospective evaluation of taste in Parkinson’s disease

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.